96 related articles for article (PubMed ID: 25198236)
1. Changes of fibroblast growth factor 23 (FGF23) levels following calcitriol treatment in a vitamin D deficient patient.
Georgoulas TI; Tournis S; Lyritis GP
J Musculoskelet Neuronal Interact; 2014 Sep; 14(3):398-400. PubMed ID: 25198236
[No Abstract] [Full Text] [Related]
2. Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23.
Mazzaferro S; Pasquali M; Pugliese F; Citterio F; Gargiulo A; Rotondi S; Tartaglione L; Conte C; Pirrò G; Taggi F
J Nephrol; 2012; 25(6):1108-18. PubMed ID: 22383345
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23.
Burnett-Bowie SA; Leder BZ; Henao MP; Baldwin CM; Hayden DL; Finkelstein JS
Clin J Am Soc Nephrol; 2012 Apr; 7(4):624-31. PubMed ID: 22300739
[TBL] [Abstract][Full Text] [Related]
4. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.
Wolf M; Koch TA; Bregman DB
J Bone Miner Res; 2013 Aug; 28(8):1793-803. PubMed ID: 23505057
[TBL] [Abstract][Full Text] [Related]
5. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
Zisman AL; Hristova M; Ho LT; Sprague SM
Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
[TBL] [Abstract][Full Text] [Related]
6. Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4-5.
Gravesen E; Hofman-Bang J; Lewin E; Olgaard K
Scand J Clin Lab Invest; 2013 Mar; 73(2):107-16. PubMed ID: 23281842
[TBL] [Abstract][Full Text] [Related]
7. Regulation of calcitriol biosynthesis and activity: focus on gestational vitamin D deficiency and adverse pregnancy outcomes.
Olmos-Ortiz A; Avila E; Durand-Carbajal M; Díaz L
Nutrients; 2015 Jan; 7(1):443-80. PubMed ID: 25584965
[TBL] [Abstract][Full Text] [Related]
8. Effects of vitamin D replacement therapy on serum FGF23 concentrations in vitamin D-deficient women in short term.
Uzum AK; Salman S; Telci A; Boztepe H; Tanakol R; Alagol F; Ozbey NC
Eur J Endocrinol; 2010 Nov; 163(5):825-31. PubMed ID: 20732956
[TBL] [Abstract][Full Text] [Related]
9. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A
Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
[TBL] [Abstract][Full Text] [Related]
10. Calcium and the endocrine system.
O'Riordan LH
Practitioner; 1982 Feb; 226(1364):237-41. PubMed ID: 6896382
[No Abstract] [Full Text] [Related]
11. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
[TBL] [Abstract][Full Text] [Related]
12. Alfacalcidol vs Calcitriol in the Management of Patient With Hypoparathyroidism: A Randomized Controlled Trial.
Saha S; Sreenivas V; Goswami R
J Clin Endocrinol Metab; 2021 Jun; 106(7):2092-2102. PubMed ID: 33616655
[TBL] [Abstract][Full Text] [Related]
13. Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol.
Isakova T; Xie H; Barchi-Chung A; Smith K; Sowden N; Epstein M; Collerone G; Keating L; Jüppner H; Wolf M
Clin J Am Soc Nephrol; 2012 May; 7(5):820-8. PubMed ID: 22383746
[TBL] [Abstract][Full Text] [Related]
14. Elevated PTH levels in hypovitaminosis D are more rapidly suppressed by the administration of 1,25-dihydroxy-vitamin D3 than by vitamin D3.
Theiler R; Bischoff H; Tyndall A; Stähelin HB
Int J Vitam Nutr Res; 1998; 68(1):36-41. PubMed ID: 9503046
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
Gutiérrez OM
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 23: the making of a hormone.
Schiavi SC
Kidney Int; 2006 Feb; 69(3):425-7. PubMed ID: 16514426
[TBL] [Abstract][Full Text] [Related]
17. Effect of Calcitriol on FGF23 Level in Healthy Adults and its Dependence on Phosphate Level.
Georgiadou E; Marketou H; Trovas G; Dontas I; Papaioannou N; Makris K; Galanos A; Papavassiliou AG
In Vivo; 2017 Jan; 31(1):145-150. PubMed ID: 28064234
[TBL] [Abstract][Full Text] [Related]
18. Regulation of fibroblast growth factor-23 in chronic kidney disease.
Westerberg PA; Linde T; Wikström B; Ljunggren O; Stridsberg M; Larsson TE
Nephrol Dial Transplant; 2007 Nov; 22(11):3202-7. PubMed ID: 17567652
[TBL] [Abstract][Full Text] [Related]
19. Intravenous Maxacalcitol Therapy Correlates with Serum Fibroblast Growth Factor 23 Levels in Hemodialysis Patients Independent of Serum Phosphate or Calcium Levels.
Ohya M; Yashiro M; Sonou T; Okuda K; Tatsuta K; Mima T; Tone Y; Negi S; Saika Y; Shigematsu T
Contrib Nephrol; 2018; 196():44-51. PubMed ID: 30041203
[TBL] [Abstract][Full Text] [Related]
20. Linear growth in relation to the circulating concentrations of insulin-like growth factor I, parathyroid hormone, and 25-hydroxy vitamin D in children with nutritional rickets before and after treatment: endocrine adaptation to vitamin D deficiency.
Soliman AT; Al Khalaf F; Alhemaidi N; Al Ali M; Al Zyoud M; Yakoot K
Metabolism; 2008 Jan; 57(1):95-102. PubMed ID: 18078865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
